comparemela.com

Latest Breaking News On - Australian stock exchange tlx ax - Page 1 : comparemela.com

Appointment of Dr Darren Patti to Group Chief Operating

MELBOURNE, Australia, March 12, 2024 (GLOBE NEWSWIRE) Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) is pleased to announce the.

United statesKyahn williamsonChristian behrenbruchTelix pharmaceuticalsAustralian therapeutic goods administrationNuclear pharmacistDarren patti as groupCompany united statesTelix pharmaceuticals limitedHealth canadaDrug administrationUniversity of illinois at chicagoCorporate communicationsAustralian securities exchangeTelix pharmaceuticals limited disclosure committeePharmaceuticals limited

Telix 2023 Full Year Results: Inaugural Profit Achieved,

MELBOURNE, Australia, Feb. 22, 2024 (GLOBE NEWSWIRE) Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces its results for the.

United statesCdx pixclaraCdx zircaixChristian behrenbruchKyahn williamsonTelix pharmaceuticals limitedAustralian securities exchangeCorporate communicationsDrug administrationTelix pharmaceuticalsTelix pharmaceuticals limited boardHealth canadaAustralian therapeutic goods administrationPharmaceuticals limitedBiologics license applicationUnited states food

Telix to Present at the 42nd Annual J P Morgan Healthcare

MELBOURNE, Australia, Jan. 03, 2024 (GLOBE NEWSWIRE) Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today advises that Dr Christian.

United statesSan franciscoUnited kingdomChristian behrenbruchLisa wilsonKyahn williamsonTelix pharmaceuticalsDrug administrationAustralian therapeutic goods administrationHealth canadaCorporate communicationsAustralian securities exchangeSite communicationsTelix pharmaceuticals limitedManaging directorHealthcare conference

Telix Radiopharmaceutical Production Facility Buildout

MELBOURNE, Australia and BRUSSELS, Belgium, March 22, 2022 (GLOBE NEWSWIRE) Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) is pleased to.

United statesWaals gewestBruxelles capitaleKyahn williamsonChristian behrenbruchTelix pharmaceuticalsDrug administrationAustralian securities exchangeAustralian therapeutic goods administrationCorporate communicationsTelix pharmaceuticals limitedBelgium federal agency for nuclear controlInvestment agencyPharmaceuticals limitedBrussels southWalloon regional

Japanese Prostate Cancer Imaging Trial Meets Study

MELBOURNE, Australia and KYOTO, Japan, Feb. 08, 2022 (GLOBE NEWSWIRE) Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) in collaboration.

United statesToshinori murayamaShintaro nishimuraStewart holmstromUnitedstatesandmaynotbeofferedorsoldwithintheunited statesChristian behrenbruchTelix pharmaceuticalsKanazawa universityDrug administrationAustralian securities exchangeAustralian therapeutic goods administrationCorporate communicationsTelix pharmaceuticals limitedTelix pharmaceuticals japanKanazawa university hospitalDepartment of clinical development

vimarsana © 2020. All Rights Reserved.